• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

New Sleep Openings Posted Today





They’re throwing decent reps under the bus to try and disguise the fact that it’s a shit drug and the launch was royally screwed up. It’s a classic Eisai maneuver.
 
































Mine was $95,000
Yeah, $95K base, but you'll be lucky to last a year. Good chance you'll be cut at some point, then your life is in chaos once again while you conduct a desperate job search that will likely takes months to secure a new gig. And in many/most cases, that new gig will pay less. Reality of the industry today, not just Eisai.